恆大(03333.HK)清盤人:將與管理層探討任何可行重組方案 附屬運作不受清盤令影響
中國恆大(03333.HK)清盤人代表安邁企業顧問公司(Alvarez & Marsal)香港董事總經理黃詠詩表示,將全力使恆大集團業務可持續運作,首要任務是盡可能保留、重組及繼續營運現有業務,將有系統地保留該集團價值,從而增加恆大向債權人及及權益持有人還款的機會。
她透露,在現有清盤程序框架內將會考慮任何可行的重組方案,接下來會與管理層開會,了解集團目前狀況及探討下一步工作,期望盡量減少對相關持份者的影響。
她強調,是次清盤令僅針對母公司中國恆大集團,不會對集團旗下附屬公司的運作造成直接影響,特別是在中國內地營運的附屬公司將不受清盤令影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.